ROX Medical Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients
San Clemente, CA | October 31, 2011
ROX Medical, Inc. today announced the first clinical use of the ROX CO2UPLER TM at the Universitair Ziekenhuis Brussel (University Hospital of Brussels) to treat resistant hypertension. "We are pleased to have performed the first ever ROX FLO2W Procedure for this new approach to hypertension, the acute impact on the patients blood pressure was greater than we expected and we look forward to understanding how much these patients benefit from the treatment over time."
ROX Medical Initiates First Commercial Activities in Germany of Minimally Invasive CO2UPLER Implant
San Clemente, CA | December 1, 2010
ROX Medical, Inc. announces start of commercial sales in Germany. The commercial launch incorporates a patient registry to capture physician and patient experiences in an effort to expand the understanding of clinical outcomes associated with the procedure.
San Clemente, CA | October 31, 2011
ROX Medical, Inc. today announced the first clinical use of the ROX CO2UPLER TM at the Universitair Ziekenhuis Brussel (University Hospital of Brussels) to treat resistant hypertension. "We are pleased to have performed the first ever ROX FLO2W Procedure for this new approach to hypertension, the acute impact on the patients blood pressure was greater than we expected and we look forward to understanding how much these patients benefit from the treatment over time."
ROX Medical Initiates First Commercial Activities in Germany of Minimally Invasive CO2UPLER Implant
San Clemente, CA | December 1, 2010
ROX Medical, Inc. announces start of commercial sales in Germany. The commercial launch incorporates a patient registry to capture physician and patient experiences in an effort to expand the understanding of clinical outcomes associated with the procedure.